Litcius/Paper detail

Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study

Piercarlo Sarzi‐Puttini, Daniela Marotto, Roberto Caporali, Carlomaurizio Montecucco, Ennio Giulio Favalli, Franco Franceschini, Micaela Fredi, Silvia Balduzzi, Chiara Bazzani, Sara Bongiovanni, Valeria Giorgi, Alberto Batticciotto, Antonella Cappelli, Patrizia Balzarini, Lorenzo Dagna, Silvia Sartorelli, Viviana Ravagnani, Silvia Tamanini, Sonia Farah, Paola Faggioli, Laura Castelnovo, Alfredo Maria Lurati, Massimo Galli, Fausto Salaffi

2020Journal of Autoimmunity33 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHydroxychloroquineTocilizumabPopulationRetrospective cohort studyCase fatality rateInternal medicineCoronavirus disease 2019 (COVID-19)DiseasePediatricsEpidemiologyInfectious disease (medical specialty)Environmental healthCOVID-19 Clinical Research StudiesRheumatoid Arthritis Research and TherapiesSARS-CoV-2 and COVID-19 Research
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study | Litcius